|
Dr. Ghanbari co-founded Panacea and serves as Chairman, CEO & Chief Scientific Officer.
Dr. Ghanbari worked at the world headquarters of Abbott Laboratories in Chicago, Illinois for more than ten years, where he developed several pharmaceuticals and the first diagnostic test for Alzheimer's Disease test marketed in the world. He served on Abbott's Technical Advisory Board and was inducted into its Volwiler Society, a prestigious honorary organization that serves as Abbott's recognition of the highest standards of scientific accomplishment.
Prior to that, he was a co-founder and served as Senior Vice-President for Research & Development of Molecular Geriatrics Corporation, a bio-pharmaceutical company that focused on developing drugs for neurodegenerative diseases. He was also the Founder, CEO, & President of Medical Toolworks, which was created to develop highly needed and innovative medical tools.
Dr. Ghanbari served as Senior Vice-President for Research & Development and Strategic Planning as well as Director for four years at Nymox Pharmaceutical Corporation. He was instrumental in starting Nymox (NASDAQ: NYMX), and was responsible for bringing in an array of technologies which have established Nymox as an international presence in the area of Alzheimer's diagnostics and therapeutics.
Dr. Ghanbari is the current Chairman of the Board of Alzheimer's Corporation of Albuquerque, New Mexico. | 